Scarica l'app Stockscreener
308.44
5.12%
15.03
Dopo l'orario di chiusura:
308.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
Geode Capital Management LLC Boosts Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
9,031 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Acquired by Wellington Management Group LLP - MarketBeat
Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) Profit Outlook - Yahoo Finance
FDA Tracker: FDA Hands Out Atopic Dermatitis Approvals to Galderma, Organon - BioSpace
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Bought by Barclays PLC - MarketBeat
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra launch key to stock's future - Investing.com
Y Intercept Hong Kong Ltd Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
How To Trade (MDGL) - Stock Traders Daily
State Street Corp Increases Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Brokerages Set Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) PT at $347.33 - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $4.74 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra's potential drives stock outlook - Investing.com India
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra's potential drives stock outlook By Investing.com - Investing.com Australia
XTX Topco Ltd Invests $1.04 Million in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy? - MSN
BNP Paribas Financial Markets Has $2.07 Million Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities - Yahoo Finance
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Position Lessened by The Manufacturers Life Insurance Company - MarketBeat
Madrigal Pharmaceuticals (LTS:0JXI) 9-Day RSI : 50.46 (As of Dec. 05, 2024) - GuruFocus.com
Madrigal Pharmaceuticals director Fred Craves sells shares worth $1.14 million - Investing.com
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is RTW Investments LP's Largest Position - MarketBeat
How to Take Advantage of moves in (MDGL) - Stock Traders Daily
Cinctive Capital Management LP Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
When Will Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Breakeven? - Simply Wall St
Charles Schwab Investment Management Inc. Boosts Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Fmr LLC Sells 5,458 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More - AOL
Martingale Asset Management L P Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals (FRA:YDO1) 9-Day RSI : 56.49 (As of Dec. 01, 2024) - GuruFocus.com
Madrigal Pharmaceuticals (FRA:YDO1) Total Assets : €967.01 Mil (As of Sep. 2024) - GuruFocus.com
Erste Asset Management GmbH Makes New $49.75 Million Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Braidwell LP Takes $39.01 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
MDGL (Madrigal Pharmaceuticals) EBITDA : $-502.65 Mil (TTM As of Sep. 2024) - GuruFocus.com
Vestal Point Capital LP Buys New Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
1,852 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Purchased by Blueshift Asset Management LLC - MarketBeat
MDGL (Madrigal Pharmaceuticals) Shares Outstanding (EOP) : 21.81 Mil (As of Sep. 2024) - GuruFocus.com
Advantage Alpha Capital Partners LP Makes New $349,000 Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Intech Investment Management LLC Takes $1.28 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals (LTS:0JXI) Total Stockholders Equi - GuruFocus.com
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move - MSN
Eagle Asset Management Inc. Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
MDGL (Madrigal Pharmaceuticals) Total Inventories : $8.72 Mil (As of Sep. 2024) - GuruFocus.com
When (MDGL) Moves Investors should Listen - Stock Traders Daily
Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication, EMA, PDMA, FDA Approvals, Epidemiology, Therapies, Companies by DelveInsight - The Globe and Mail
Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra - MSN
Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024? - Insider Monkey
Madrigal Pharmaceuticals Engages with Investors at Key Conferences - MSN
Connor Clark & Lunn Investment Management Ltd. Decreases Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal shares hold as Cowen maintains price target on new data - Investing.com Canada
Madrigal Pharmaceuticals (FRA:YDO1) Peter Lynch Fair Value : N/A (As of Nov. 20, 2024) - GuruFocus.com
Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra (MDGL:NASDAQ) - Seeking Alpha
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):